Skip to main content
. 2019 Dec 20;9:1458. doi: 10.3389/fonc.2019.01458

Figure 2.

Figure 2

Overview of rhabdomyosarcoma targeted therapies organized by pathway. Therapeutically actionable targets (at least one existing small molecule inhibitor or antibody) are indicated with an asterisk (*).